このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Pictorial Warning Labels, Numeracy, and Memory for Numeric Cigarette Health-risk Information Over Time

2018年4月10日 更新者:Ellen Peters、Ohio State University
Pictorial cigarette warning labels (PWLs) are thought to increase risk knowledge, but experimental research has not examined PWLs' longer term effects on memory for health risks, or for numeric risks (e.g., percentage risk for developing lung cancer). This trial tests memory for numeric health risks immediately or after a six-week delay for US adult smokers. In addition, the trial tests the effects of different warning label components (e.g., whether the numeric risks are percentage or frequency), participants' level of numeric ability, and the consequences of memory for numeric risks on participant risk perceptions and quit intentions.

調査の概要

研究の種類

介入

入学 (実際)

866

段階

  • 適用できない

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

18年歳以上 (大人、高齢者)

健康ボランティアの受け入れ

はい

受講資格のある性別

全て

説明

Inclusion Criteria:

  • at least 18 years old
  • have smoked 100+ lifetime cigarettes
  • currently smoke "every day" or "some days."
  • US resident

Exclusion Criteria:

  • have not ever smoked a cigarette

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:防止
  • 割り当て:ランダム化
  • 介入モデル:階乗代入
  • マスキング:ダブル

武器と介入

参加者グループ / アーム
介入・治療
実験的:Text-only PWL, immediate post

Exposure to 4 FDA-mandated warning labels and numeric risk information for 8 outcomes related to those warnings (2 outcomes for each PWL; half as percentage, half as frequency)

Posttest measures (e.g., memory, risk perceptions, quit intentions) administered immediately following last exposure to warning labels

実験的:Text-only PWL, delay posttest

Exposure to 4 FDA-mandated warning labels and numeric risk information for 8 outcomes related to those warnings (2 outcomes for each PWL; half as percentage, half as frequency)

Posttest measures (e.g., memory, risk perceptions, quit intentions) administered 6 weeks following last exposure to warning labels

実験的:Low-emot PWL, immed post

Exposure to 4 FDA-mandated warning labels paired with images that elicit little emotion and numeric risk information for 8 outcomes related to those warnings (2 outcomes for each PWL; half as percentage, half as frequency)

Posttest measures (e.g., memory, risk perceptions, quit intentions) administered immediately following last exposure to warning labels

実験的:Low-emot PWL, delay posttest

Exposure to 4 FDA-mandated warning labels paired with images that elicit little emotion and numeric risk information for 8 outcomes related to those warnings (2 outcomes for each PWL; half as percentage, half as frequency)

Posttest measures (e.g., memory, risk perceptions, quit intentions) administered 6 weeks following last exposure to warning labels

実験的:High-emot PWL, immed posttest

Exposure to 4 FDA-mandated warning labels paired with images that elicit high emotion and numeric risk information for 8 outcomes related to those warnings (2 outcomes for each PWL; half as percentage, half as frequency)

Posttest measures (e.g., memory, risk perceptions, quit intentions) administered immediately following last exposure to warning labels

実験的:High-emot PWL, delay posttest

Exposure to 4 FDA-mandated warning labels paired with images that elicit high emotion and numeric risk information for 8 outcomes related to those warnings (2 outcomes for each PWL; half as percentage, half as frequency)

Posttest measures (e.g., memory, risk perceptions, quit intentions) administered 6 weeks following last exposure to warning labels

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
numeric risk recall
時間枠:immediately following last exposure or after 6-week delay
free recall for numeric risks presented in labels (e.g., ____% of smokers die before age 85), both for smokers and nonsmokers
immediately following last exposure or after 6-week delay
numeric risk recognition
時間枠:immediately following last exposure or after 6-week delay
Participants answered one multiple choice question about the numeric risk for smokers and nonsmokers (combined in one question) for each of the 8 outcomes that had been paired with the PWLs. For each question, there were four decoy responses.
immediately following last exposure or after 6-week delay

二次結果の測定

結果測定
メジャーの説明
時間枠
smoking risk perceptions
時間枠:immediately following last exposure or after 6-week delay

Participants completed several scale items about how much risk they perceived smoking posed to them (e.g., "Compared to the average nonsmoker your age, gender, and race, how would you rate your chances of": 1) "getting a life threatening illness because of smoking," 2) "getting lung cancer," and 3) "dying at a younger age than average" (-3 = Much lower, +3 = Much higher))

They also gave verbal likelihood ratings for each of the 8 outcomes of smoking that had been paired with the labels (e.g., "Thinking of risks that you were shown in the warnings, what is the likelihood of a smoker [non-smoker] dying from heart disease?," 0=impossible, 11=certain)

immediately following last exposure or after 6-week delay
smoking risk knowledge
時間枠:immediately following last exposure or after 6-week delay
Participants listed as many risks of smoking as they could think of.
immediately following last exposure or after 6-week delay
quit intentions
時間枠:immediately following last exposure or after 6-week delay
Participants intentions to quit smoking, Likelihood of smoking within next 30 days, next year (-3 = very unlikely, 3 = very likely)
immediately following last exposure or after 6-week delay

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2016年4月16日

一次修了 (実際)

2016年6月2日

研究の完了 (実際)

2016年6月2日

試験登録日

最初に提出

2018年4月10日

QC基準を満たした最初の提出物

2018年4月10日

最初の投稿 (実際)

2018年4月18日

学習記録の更新

投稿された最後の更新 (実際)

2018年4月18日

QC基準を満たした最後の更新が送信されました

2018年4月10日

最終確認日

2018年4月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • P50CA180908A2b
  • P50CA180908 (米国 NIH グラント/契約)

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

ポストテストを遅らせるの臨床試験

3
購読する